Important notes from the latest PR (other than the details on promissory note):
-EUA is submitted and waiting determination by FDA -Company in Large negotiations with Russian partner - Other potential distribution partnership in EU, Africa and Middle East
“The company's new GenViro!TM product designed to test for the Coronavirus Covid-19 is not yet available in the United States or Puerto Rico but Emergency Waivers have been submitted and are awaiting determination.
This is how they do it. Provide a vague reference in a PR with different terminology (emergency waiver) and then let the minions propagate the rumor. Spreads like a brush fire. berman can claim plausible deniability.